| Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. AK Ryan, K Bartlett, P Clayton, S Eaton, L Mills, D Donnai, RM Winter, ... Journal of medical genetics 35 (7), 558-565, 1998 | 268 | 1998 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 178 | 2018 |
| Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) N Lintzeris, L Mills, A Suraev, M Bravo, T Arkell, JC Arnold, MJ Benson, ... Harm reduction journal 17, 1-12, 2020 | 97 | 2020 |
| Nabiximols for the treatment of cannabis dependence: a randomized clinical trial N Lintzeris, A Bhardwaj, L Mills, A Dunlop, J Copeland, I McGregor, ... JAMA internal medicine 179 (9), 1242-1253, 2019 | 90 | 2019 |
| The social media index as an indicator of quality for emergency medicine blogs: a METRIQ study B Thoma, TM Chan, P Kapur, D Sifford, M Siemens, M Paddock, F Ankel, ... Annals of emergency medicine 72 (6), 696-702, 2018 | 51 | 2018 |
| Individual gestalt is unreliable for the evaluation of quality in medical education blogs: a METRIQ study B Thoma, SS Sebok-Syer, K Krishnan, M Siemens, NS Trueger, ... Annals of emergency medicine 70 (3), 394-401, 2017 | 38 | 2017 |
| Opioid agonist treatment and patient outcomes during the COVID‐19 pandemic in south east Sydney, Australia N Lintzeris, RM Deacon, V Hayes, T Cowan, L Mills, L Parvaresh, ... Drug and alcohol review 41 (5), 1009-1019, 2022 | 36 | 2022 |
| Driving-related behaviours, attitudes and perceptions among Australian medical cannabis users: results from the CAMS 18-19 survey TR Arkell, N Lintzeris, L Mills, A Suraev, JC Arnold, IS McGregor Accident Analysis & Prevention 148, 105784, 2020 | 34 | 2020 |
| Placebo caffeine reduces withdrawal in abstinent coffee drinkers L Mills, RA Boakes, B Colagiuri Journal of Psychopharmacology 30 (4), 388-394, 2016 | 25 | 2016 |
| Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20) N Lintzeris, L Mills, SV Abelev, A Suraev, JC Arnold, IS McGregor Harm reduction journal 19 (1), 88, 2022 | 24 | 2022 |
| Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial N Lintzeris, L Mills, A Dunlop, J Copeland, I Mcgregor, R Bruno, A Kirby, ... Drug and Alcohol Dependence 215, 108220, 2020 | 23 | 2020 |
| Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history B Meiser, VF Quinn, G Mitchell, K Tucker, KJ Watts, B Rahman, M Peate, ... European Journal of Human Genetics 26 (7), 972-983, 2018 | 22 | 2018 |
| Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations RM Deacon, K Mammen, J Holmes, A Dunlop, R Bruno, L Mills, ... Drug and alcohol review 39 (5), 441-446, 2020 | 19 | 2020 |
| Modelling generalisation gradients as augmented Gaussian functions JC Lee, L Mills, BK Hayes, EJ Livesey Quarterly Journal of Experimental Psychology 74 (1), 106-121, 2021 | 18 | 2021 |
| Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian treatment outcomes profile (ATOP) in alcohol and opioid treatment … RM Deacon, K Mammen, R Bruno, L Mills, A Dunlop, J Holmes, ... Addiction 116 (5), 1245-1255, 2021 | 17 | 2021 |
| Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition L Mills, N Lintzeris, M O'Malley, JC Arnold, IS McGregor Drug and alcohol review 41 (5), 1095-1108, 2022 | 14 | 2022 |
| A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depression L Mills, B Meiser, R Ahmad, PR Schofield, M Peate, C Levitan, L Trevena, ... BMC psychiatry 19, 1-11, 2019 | 12 | 2019 |
| Australian Treatment Outcomes Profile (ATOP) manual 1: using the ATOP with individual clients N Lintzeris, K Mammen, J Holmes, R Deacon, L Mills, E Black, L Gardner, ... Sydney, Australia: AoD Treatment Clinical Outcomes and Quality Indicators …, 2020 | 11 | 2020 |
| Effect of genetic information and information about caffeine content on caffeine withdrawal symptoms L Mills, I Dar-Nimrod, B Colagiuri Scientific Reports 7 (1), 8407, 2017 | 11 | 2017 |
| The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction L Mills, RA Boakes, B Colagiuri Journal of Psychopharmacology 33 (8), 994-1002, 2019 | 10 | 2019 |
